Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBIS-3 high-dose rosuvastatin coronary plaque imaging study
NL-OMON24500Recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rosuvastatin in coronary arteriosclerosis, sponsored by Erasmus MC. Primary endpoint: Change in necrotic core volume. Started Feb 2010; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON24500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24500.